If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
1
Followers on Owler
Medisix Therapeutics
focuses on developing chimeric antigen receptor T cells for the treatment of lymphoma and leukemia...
Read more
Overview
Competitors
Funding
News & Insights
Medisix Therapeutics
focuses on developing chimeric antigen receptor T cells for the treatment of lymphoma and leukemia...
Read more
Founder
Dario Campana
CEO Approval Rating
78/100
Weigh In
2016
Singapore
Other
Private
Pharmaceuticals & Biotechnology
Biotechnology
2836
NAICS listing
http://medisixtx.com/
Est. Annual Revenue
$1.1M
Agree?
Yes
No
Est. Employees
<10
Agree?
Yes
No
Funding
$20M
News
Latest News
Apr 07, 2022
Benzinga
Medisix Therapeutics: Twist Bioscience Inks Antibody Discovery Pact With MediSix Therapeutics
Follow and Get Alerts
Medisix Therapeutics Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 36 + competitors
Trending Companies
